Experimental drug targets multiple advanced cancers in first human test
Disease control
Recruiting now
This early-stage trial is testing a new cancer drug called NN3201 for the first time in people. The study aims to find a safe dose and see how well the drug works against several advanced solid tumors that have a specific protein called c-Kit. Researchers will enroll 67 adults wi…
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC